icosapent ethyl

FDA Drug Profile — icosapent ethyl, Vascepa, ICOSAPENT ETHYL

Drug Details

Generic Name
icosapent ethyl
Brand Names
icosapent ethyl, Vascepa, ICOSAPENT ETHYL
Application Number
ANDA217656
Sponsor
Patheon Softgels B.V.
NDC Codes
29
Dosage Forms
CAPSULE, CAPSULE, LIQUID FILLED
Routes
ORAL
Active Ingredients
ICOSAPENT ETHYL

Indications and Usage

1 INDICATIONS AND USAGE Icosapent ethyl capsules are indicated: as an adjunct to diet to reduce TG levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia. Limitations of Use: The effect of icosapent ethyl capsules on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined. Icosapent ethyl capsules are an ethyl ester of eicosapentaenoic acid (EPA) indicated: as an adjunct to diet to reduce TG levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia. ( 1 ) Limitations of Use : The effect of icosapent ethyl capsules on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined. ( 1 )